Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 12, 2011

Oral Laquinimod For MS Treatment Significantly Reduced Disease Activity And Disability Progression While Providing Good Safety And Tolerability

  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
April 12, 2011 Teva Pharmaceutical Industries Ltd. and Active Biotech announced today results from the two-year Phase III ALLEGRO study…
Multiple Sclerosis

April 12, 2011

Mayo Clinic Finds Tool To Predict Disability Timeline For Progressive MS Patients

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
April 12, 2011 Many patients with progressive multiple sclerosis (MS) worry how quickly the disease will progress. Now, by noting the presence…
MS Research Study and Reports

April 11, 2011

Biogen Oral MS Pill Meets Goals of Study

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
April 11, 2011 By THOMAS GRYTA Biogen Idec Inc.’s oral drug for multiple sclerosis showed success in the first of two large…
MS Drug Therapies

April 11, 2011

Media Release: Novartis therapy GilenyaTM reduced the risk of MS disability progression regardless of disease severity

  • Oral MS Medications
    /
Novartis therapy GilenyaTM reduced the risk of MS disability progression regardless of treatment history or disease severity, new analysis shows…
Oral MS Medications

April 8, 2011

Laquinimod, Alemtuzumab, CCSVI, and much more, to be discussed at the AAN meeting in Hawaii, April 9th thru 16th

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Showing just a few of what will be discussed:    Teva to present Laquinimod data at Hawaii conference Globes Online…
MS Research Study and Reports

April 8, 2011

Tysabri Label Modified to Include More Brain Infection Data

  • Multiple Sclerosis
    /
  • Tysabri
    /
April 8, 2011 Tysabri, the multiple sclerosis drug marketed by Biogen Idec Inc. and Elan Corp is having its label updated…
Multiple Sclerosis

April 8, 2011

More evidence pregnancy is safe with MS

  • Multiple Sclerosis
    /
By Amy Norton NEW YORK | Thu Apr 7, 2011 4:23pm EDT (Reuters Health) – A new research review strengthens the evidence…
Multiple Sclerosis

April 8, 2011

Warm or ever Hot weather – and how it can affect the MS patient

  • Multiple Sclerosis
    /
  • Symptoms
    /
source: National MS Society A study linking warmer weather with problems with thinking tasks in people with MS is among thousands…
Multiple Sclerosis

April 8, 2011

Pediatric MS: Self-Advocacy and the Healthcare Team

  • Multiple Sclerosis
    /
  • National MS Society Related
    /
The National MS Society’s  Learn ONLINE New Feature Presentation: Pediatric MS: Self-Advocacy and the Healthcare Team  A video webcast that explores… Teaching a child…
Multiple Sclerosis

April 6, 2011

Solu-Medrol: The Good, The Bad and The Ugly

  • Additional MS resource sites
    /
  • Multiple Sclerosis
    /
   > Many of us with multiple sclerosis (MS) have taken the Solu-Medrol “journey.” While the benefits can seem miraculous…
Additional MS resource sites

Categories

Latest Blog Posts